Underlying Autoimmune Disease Is Not a Contraindication to the Use of Ipilimumab
JAMA Oncology - United States
doi 10.1001/jamaoncol.2015.4717
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2016
Authors
Publisher
American Medical Association (AMA)